SE8600501L - Preparat for behandling av nagelsvamp och seborroiskt eksem - Google Patents

Preparat for behandling av nagelsvamp och seborroiskt eksem

Info

Publication number
SE8600501L
SE8600501L SE8600501A SE8600501A SE8600501L SE 8600501 L SE8600501 L SE 8600501L SE 8600501 A SE8600501 A SE 8600501A SE 8600501 A SE8600501 A SE 8600501A SE 8600501 L SE8600501 L SE 8600501L
Authority
SE
Sweden
Prior art keywords
treatment
seborous
ecsc
preparation
weight
Prior art date
Application number
SE8600501A
Other languages
English (en)
Other versions
SE462139B (sv
SE8600501D0 (sv
Inventor
Sven Moberg
Original Assignee
Sven Moberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Moberg filed Critical Sven Moberg
Priority to SE8600501A priority Critical patent/SE462139B/sv
Publication of SE8600501D0 publication Critical patent/SE8600501D0/sv
Priority to DE8787901161T priority patent/DE3773201D1/de
Priority to AU70239/87A priority patent/AU599086B2/en
Priority to PCT/SE1987/000053 priority patent/WO1987004617A1/en
Priority to EP87901161A priority patent/EP0292495B1/en
Priority to AT87901161T priority patent/ATE67409T1/de
Publication of SE8600501L publication Critical patent/SE8600501L/sv
Priority to DK519387A priority patent/DK165440C/da
Priority to NO874150A priority patent/NO174764C/no
Priority to CA000573123A priority patent/CA1330198C/en
Publication of SE462139B publication Critical patent/SE462139B/sv
Priority to US08/150,245 priority patent/US5525635A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
SE8600501A 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem SE462139B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8600501A SE462139B (sv) 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AT87901161T ATE67409T1 (de) 1986-02-04 1987-02-04 Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile.
EP87901161A EP0292495B1 (en) 1986-02-04 1987-02-04 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components
AU70239/87A AU599086B2 (en) 1986-02-04 1987-02-04 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
PCT/SE1987/000053 WO1987004617A1 (en) 1986-02-04 1987-02-04 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
DE8787901161T DE3773201D1 (de) 1986-02-04 1987-02-04 Arzneimittel enthaltend propylenglykol und/oder polyaethylenglykol sowie harnstoff als hauptbestandteile.
DK519387A DK165440C (da) 1986-02-04 1987-10-02 Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
NO874150A NO174764C (no) 1986-02-04 1987-10-02 Fremgangsmåte for fremstilling av et preparat som er virksomt ved behandling av hyperkeratotiske og andre hudsykdommer
CA000573123A CA1330198C (en) 1986-02-04 1988-07-27 Pharmaceutical composition containing propylene glycol and urea as active main components and use thereof
US08/150,245 US5525635A (en) 1986-02-04 1993-11-09 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600501A SE462139B (sv) 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem

Publications (3)

Publication Number Publication Date
SE8600501D0 SE8600501D0 (sv) 1986-02-04
SE8600501L true SE8600501L (sv) 1987-08-05
SE462139B SE462139B (sv) 1990-05-14

Family

ID=20363358

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600501A SE462139B (sv) 1986-02-04 1986-02-04 Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem

Country Status (9)

Country Link
EP (1) EP0292495B1 (sv)
AT (1) ATE67409T1 (sv)
AU (1) AU599086B2 (sv)
CA (1) CA1330198C (sv)
DE (1) DE3773201D1 (sv)
DK (1) DK165440C (sv)
NO (1) NO174764C (sv)
SE (1) SE462139B (sv)
WO (1) WO1987004617A1 (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
DE4322395C1 (de) * 1993-07-01 1994-07-28 Kuehnl Petzoldt Christa Dr Med Duschlotion zur Behandlung und Pflege trockener Haut
US5916545A (en) * 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
SE9403541L (sv) * 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
CA2266496A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
ATE213939T1 (de) * 1997-11-25 2002-03-15 Yamanouchi Europ Bv Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen
EP1709960A3 (en) * 1998-02-13 2006-12-20 Carol J. Buck Use of alkanoic acid-containing compositions for straightening hair
AUPQ002999A0 (en) * 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
US6835385B2 (en) 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US6858215B2 (en) 2002-06-14 2005-02-22 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
JP2005538156A (ja) * 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液
WO2005115368A1 (en) * 2004-05-31 2005-12-08 Al Tayeb Fayez Hussien Carrier composition for topical formulations
EP1683511A1 (fr) * 2005-01-13 2006-07-26 Laboratoires S.V.R. Produit squamo-régulateur à base d'urée et son application en cosmétologie
WO2007054833A2 (en) 2005-11-14 2007-05-18 L'oréal Cosmetic use of a hydroxyalkylurea as an agent for treating desquamative conditions of the scalp; cosmetic treatment compositions and processes
WO2008046796A2 (en) * 2006-10-20 2008-04-24 Symrise Gmbh & Co. Kg Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
US20140205639A1 (en) * 2013-01-22 2014-07-24 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2316436A1 (en) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Tape, in particular adhesive tape, for the treatment of skin disorders comprising a film , in particular dissolvable film, containing at least one enzyme
EP2316438A1 (en) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Tape , in particular adhesive tape, for the treatment of skin disorders comprising at least one hyperkeratosis inhibitor and/or at least one keratinolytic agent
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
WO2012110430A1 (en) 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
US9492407B2 (en) 2011-05-12 2016-11-15 Auxilium Cura Innovatio Topical formulation for treatment of hyperkeratotic skin
WO2014140507A1 (en) * 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395236A (en) * 1961-09-28 1968-07-30 Cleveland J. White Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
SE325667B (sv) * 1968-03-06 1970-07-06 Medisan Ab
DE2608221B1 (de) * 1976-02-28 1977-07-21 Beiersdorf Ag Kosmetisches mittel zur glaettung der haut
US4239781A (en) * 1979-05-03 1980-12-16 Roy Edwards Method for treating skin ailments
DE3210138A1 (de) * 1982-03-19 1983-09-22 Röhm Pharma GmbH, 6100 Darmstadt Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis
AU570998B2 (en) 1983-09-07 1988-03-31 Takeda Chemical Industries Ltd. Topical steroid compositions for acne

Also Published As

Publication number Publication date
WO1987004617A1 (en) 1987-08-13
NO174764C (no) 1994-07-06
SE462139B (sv) 1990-05-14
EP0292495B1 (en) 1991-09-18
DE3773201D1 (de) 1991-10-24
DK165440C (da) 1993-04-13
NO874150D0 (no) 1987-10-02
DK519387D0 (da) 1987-10-02
AU7023987A (en) 1987-08-25
NO874150L (no) 1987-12-02
CA1330198C (en) 1994-06-14
DK519387A (da) 1987-10-02
EP0292495A1 (en) 1988-11-30
NO174764B (no) 1994-03-28
AU599086B2 (en) 1990-07-12
SE8600501D0 (sv) 1986-02-04
ATE67409T1 (de) 1991-10-15
DK165440B (da) 1992-11-30

Similar Documents

Publication Publication Date Title
SE8600501D0 (sv) Preparat for behandling av nagelsvamp och seborroiskt eksem
PE799A1 (es) Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
BRPI0512583A (pt) composições e métodos de produção das mesmas, de liberação de agente ativo para e através do tecido da epiderme de pessoa ou animal e de tratamento de paciente que sofre de onicomicose, de psorìase de unha e de infecções
ATE468889T1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
DE50012571D1 (de) Biotin enthaltende galenische formulierung
DE3681647D1 (de) Praeparat mit wirkung gegen akne sowie verwendung von wirkstoffextrakt des queckenweizens.
JPS55108860A (en) Hydroxypropylltriazole*its manufacture and use as medicine
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
US3395236A (en) Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
EE200100188A (et) Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
ATE69550T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
JPS55160712A (en) Emulsified cosmetic composition
ATE3552T1 (de) Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel.
NO941097D0 (no) Hudregenererende kosmetisk preparat
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
FI79466B (fi) Haorvaextmedel.
ES2156446T3 (es) Formulacion farmaceutica semisolida que contiene dexketoprofeno trometanol.
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5&#39;-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8600501-4

Format of ref document f/p: F

NUG Patent has lapsed